We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STG:NYSESunlands Technology Group Analysis

Data as of 2026-08-01 - not real-time

$3.29

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Sunlands Technology Group (STG) is trading at $3.29, well below its 20‑day ($3.69) and 50‑day ($3.59) simple moving averages, and the RSI of 40 suggests the stock is not yet oversold. Technical indicators are bearish – the MACD histogram is negative and volume is declining, while volatility is extreme at 119% over the past 30 days. Fundamentally, the company boasts razor‑thin valuation multiples – a trailing PE of 0.84, price‑to‑book of 0.30 and price‑to‑sales of 0.02, yet revenue contracted 9.6% year‑over‑year and forward EPS is projected negative. The balance sheet shows ample cash ($782 M) offset by a high debt‑to‑equity ratio of 13, and operating cash flow is currently zero, raising concerns about cash conversion. Regulatory risk looms large for Chinese education firms, and the upcoming Q1 2026 earnings call on May 26 will be a key catalyst for direction.
Given the combination of deep discount valuation, strong gross margins (87%) and operating margins (22%) against a backdrop of revenue decline, high volatility, and a hostile regulatory environment, investors should treat STG as a high‑risk, potentially undervalued play that may reward patience if the company can stabilize earnings and navigate policy constraints.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term moving averages and bearish MACD
  • Decreasing volume and extreme short‑term volatility
  • Pending earnings release may clarify near‑term direction

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Deep valuation discounts (PE, PB, PS) provide upside potential
  • Revenue contraction and zero operating cash flow limit confidence
  • Regulatory environment for adult education in China remains uncertain

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong cash cushion relative to debt and high gross margins
  • Potential for earnings recovery if regulatory pressure eases
  • Undervalued multiples suggest significant upside if fundamentals improve

Key Metrics & Analysis

Financial Health

Revenue Growth-9.60%
Profit Margin18.62%
P/E Ratio0.8
ROE44.10%
ROA14.18%
Debt/Equity13.03
P/B Ratio0.3

Technical Analysis

TrendNeutral
RSI40.5
Support$3.27
Resistance$4.14
MA 20$3.69
MA 50$3.59
MA 200$4.63
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.61
Volatility119.45%
Sector RiskLow
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.